The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Neuronal Synuclein Disease Endotypes 2024, 2025Integrated Analysis of Alpha-synuclein in the North American Prodromal Synucleinopathy (NAPS) Cohort
Study Rationale: REM sleep behavior disorder is well recognized as a prodromal condition associated with a high risk of subsequently developing neurodegenerative disorders termed synucleinopathies...
-
Research Grant, 2025Construction of a Living Library of Digital Technologies for Use in Research and Care of Parkinson’s Disease.
Study Rationale: Interest in digital technologies within Parkinson’s disease (sensors, devices, specific smartphone apps) for early detection and disease monitoring has increased in recent years. Over...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Identifying Biochemical, Histological and Molecular Signatures of Constipation Associated with Parkinson’s Disease
Study Rationale: Constipation is one of the most common non-motor symptoms of Parkinson’s disease (PD). It occurs in 50 to 80 percent of people with PD and doubles the risk of PD diagnosis after 10...
-
Research Grant, 2025Discovery of Alpha-synuclein PET Tracer for Parkinson’s Disease
Study Rationale: In Parkinson’s disease (PD), a protein called alpha-synuclein builds up inside of brain cells. Research suggests that this protein accumulation damages the cells and eventually leads...
-
Research Grant, 2025Identifying Protein Changes Associated with Parkinson’s Disease: Proteomics Public Data Compilation
Study Rationale: Accumulation of toxic protein aggregates is a hallmark of neurodegenerative disorders that include Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA)...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Elucidating the Role of PINK1 and PRKN in Cell Type-specific Responses to Alpha-synuclein Pathology
Study Rationale: Parkinson’s disease (PD) is associated with loss of dopamine neurons and aggregation of the protein alpha-synuclein. Mutations that impair the function of PINK1 and PRKN, proteins...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.